Project Grant R21AI199466
Award Date 5/6/26
Completion Date 4/30/28
Dollars Obligated $209K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Indianapolis, IN 46202, USA
Similar Awards
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the Board of Regents of the University of Nebraska, through its University of Nebraska Medical Center (UNMC) division, a Project Grant of $230,250 under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award, obligated on August 12, 2025, with a completion date of July 31, 2027, supports investigator-initiated biomedical research examining the mechanisms of dynein-mediated...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Tufts University School of Medicine a Project Grant of $6.32 million under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective August 1, 2025, through July 31, 2029. This four-year research initiative supports investigator-initiated biomedical research focused on understanding how Human Papillomavirus (HPV)-encoded E7 proteins reprogram host cell signaling pathways to...
- Federal Project Grant Award Summary Northwestern University's Sponsored Research Division received a $240,000 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded February 6, 2026, with a completion date of January 31, 2028. The grant supports investigator-initiated biomedical research examining human papillomavirus (HPV)-induced R-loop formation and its regulatory effects on...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $281,480 Project Grant to the University of Maryland, Baltimore on September 12, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855). This five-year research initiative, with a completion date of August 31, 2030, will conduct a secondary analysis of existing human papillomavirus (HPV) natural history cohort samples to investigate the role of sex hormones...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a Project Grant of $811,033 to the University of Texas Medical Branch at Galveston on September 4, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award will support the HPV and Risk to Pregnancy (HARP) Study, a prospective cohort research initiative extending through August 31, 2030. This study will enroll 1,280 pregnancies across three clinical sites to...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Stanford University a Project Grant of $131,166 under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period August 1, 2025, through July 31, 2027. This award supports postdoctoral research training and career development focused on identifying protective T cell epitopes for human papillomavirus (HPV) therapeutic vaccine development. The research represents a shift...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Wisconsin–Madison a Project Grant totaling $524,626 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on February 5, 2026, for research extending through January 31, 2031. This award supports an investigator-initiated biomedical research project titled "A Chromatin Loop Controls the Expression of Anterograde Transport Genes During HSV-1...
- Federal Grant Award Summary Meharry Medical College received a $400,125 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective June 17, 2025, through May 31, 2027. The award funds research investigating a novel mechanism by which HIV-1 (Human Immunodeficiency Virus-1) evades the antiviral function of APOBEC3G (A3G), a cellular restriction factor that normally inhibits viral...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Arkansas for Medical Sciences $420,335 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on June 23, 2025, for a project period extending through May 31, 2027. The project investigates the role of lytic viral genes in the pathogenesis of oncogenic gammaherpesviruses, specifically examining whether lytic gene expression drives the development and...
- Federal Project Grant Award Summary The University of Nebraska Medical Center (UNMC) received a $417,845 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective April 5, 2026, with a completion date of February 28, 2031. This research initiative investigates the biological roles and mechanisms of cell surface ribonucleic acids (RNAs) in human papillomavirus (HPV) endocytic...